Blog
Leaving Neuroendocrine Cancer Behind
NET Survivor Finds Hope and Inspiration That’s it—my number is up, Dave McCoy thought when he learned he had neuroendocrine cancer in 2008. A cancer, he
October 11, 2018
6 Comments
Category: Patient Care
About NETRF
The Neuroendocrine Tumor Research Foundation (NETRF) is the leading private funder of research into causes and treatments of neuroendocrine tumors (NETs) to improve and extend the lives of those living with NETs.
For Researchers
Immunotherapy Update: What We’ve Learned
Immunotherapy has been called one of the most significant advances in cancer in decades. While this approach may work in some cancers, it is unclear
September 27, 2018
No Comments
Blog
Immunotherapy Update: What We’ve Learned
Immunotherapy has been called one of the most significant advances in cancer in decades. While this approach may work in some cancers, it is unclear
September 11, 2018
1 Comment
Blog
The passing of Aretha Franklin, Queen of Soul
We are saddened to hear of the passing of Aretha Franklin, the Queen of Soul, who died of a pancreatic neuroendocrine tumor (pNET). She was
August 16, 2018
2 Comments
Blog
Study to Look for Predictive Biomarker
New Potential NET Treatment under Investigation It is hard for doctors to know which patients will respond to which therapies. New approaches in personalized medicine
August 9, 2018
No Comments
Blog
Understanding Your Neuroendocrine Tumor Diagnosis
Understanding the grade and stage of neuroendocrine cancer and how that relates to prognosis.
August 3, 2018
2 Comments
Blog
FDA Approves New Treatment for Pheo/Para
The U.S. Food and Drug Administration (FDA) approved iobenguane I 131, an intravenous radiotherapeutic, for the treatment of unresectable, locally advanced or metastatic pheochromocytoma or
August 3, 2018
No Comments
Blog
Preparing for the Disaster
Natural or man-made disasters often occur with little or no notice. Being prepared for a disaster is important for everyone, but cancer patients and survivors
August 3, 2018
No Comments
Blog
A Blessing in Disguise?
David Van Bibber calls his neuroendocrine cancer diagnosis a blessing in disguise.it. Since his 2010 diagnosis at the age of 32, David’s priorities and perspectives have changed. As a result, he has invested more deeply in his health, his family, and his community. Now he is reaping the rewards of that investment and finding daily joy in his life.
August 2, 2018
7 Comments
Blog
NET Patients: Are you Scheduled for Surgery?
If you are having surgery for a NET tumor, consider donating some of your tumor tissue to help research. The Neuroendocrine Tumor Research Foundation is
July 10, 2018
1 Comment